Matrix Tablet Containing Quaternary Inclusion Complex of Domperidone for Treatment of Diabetic Gastroparesis
Vishwajeet Sampatrao Ghorpade1, Kailas Krishnat Mali1★, Remeth Jacky Dias1, Vijay Daulatrao Havaldar1, Ganesh Shankar Raut1★ Corresponding author
- 1Department of Pharmaceutics, YSPM’s Yashoda Technical Campus, Wadhephata, Satara, Maharashtra, INDIA.
CORRESPONDENCE
Kailas Krishnat Mali
Department of Pharmaceutics, YSPM’s Yashoda Technical Campus, Wadhephata, Satara, Maharashtra, INDIA.
Received: 11-04-2017; Revised: 13-07-2017; Accepted: 27-09-2017.
Volume 51, Issue 4S · pp. s588–s600 · PUBLISHED 2017 · DOI: 10.5530/ijper.51.4s.87
ABSTRACT
Objective: The present investigation is aimed at development and optimization of a pH independent controlled release matrix tablet containing mannitol based quaternary inclusion complex (QIC) of domperidone (DOM) for the treatment of diabetic gastroparesis. Methods: The tablets were prepared by direct compression and central composite design was used to optimize the amount of sodium alginate (SA) and hydroxypropylmethylcellulose (HPMC) to obtain a final formulation with desired release characteristics. The drug release from the optimized formulation was compared with the tablets containing pure DOM, binary and ternary inclusion complexes. Results and Discussion: The formulations showed a zero order release profile. The design models suggested greater influence of SA on the drug release. The optimized formulation showed minimum burst effect and released 88.65±3.19% DOM at the end of 12 h. The comparative study revealed that the optimized formulation exhibited nearly complete release of DOM. Conclusion: It was concluded that the optimized formulation containing QIC may reduce the dose frequency and improve the bioavailability of DOM.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Ghorpade, V. S., Mali, K. K., Dias, R. J., Havaldar, V. D., & Raut, G. S. (2017). Matrix Tablet Containing Quaternary Inclusion Complex of Domperidone for Treatment of Diabetic Gastroparesis. Indian Journal of Pharmaceutical Education and Research, 51(4S), s588–s600. https://doi.org/10.5530/ijper.51.4s.87
